Fingerprint
Dive into the research topics of 'Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial
Ioana R. Preston, Charles D. Burger, Sonja Bartolome, Zeenat Safdar, Michael Krowka, Namita Sood, Hubert J. Ford, Wejdan F. Battarjee, Murali M. Chakinala, Mardi Gomberg-Maitland, Nicholas S. Hill
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations